Publication Month: Jun 2021 | Report Code: TIPRE00005166 | No. of Pages: 204 | Category: Biotechnology | Status: Published
Molecular quality controls help to monitor the performance of testing procedures. These tests are helpful to achieve critical and accurate diagnostic information. These controls are used to determine transmissible and genetic diseases too. Moreover, the molecular quality controls also help to monitor the performance of nucleic acid testing protocols for healthcare associated infections, viral load assays and sexually transmitted infections. The growth of the molecular quality controls market is attributed to the factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.
Get more information on this report :
Molecular quality controls are used to detect genetic diseases as these aid in the interpretation of results. Downs Syndrome is a genetic disorder that causes due to abnormal cell division, which results in an extra full or partial copy of chromosome 21. As per the US Centers for Disease Control and Prevention (CDC), every year, around 6,000 newborns in the US suffer from the Down syndrome. As a result, prenatal testing for Down syndrome is increasing in the country.
Most of the inherited cases of breast cancer are associated with mutations in two genes: BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). As per the American Cancer Society, around 5% to 10% of breast cancer cases are hereditary, as a result of mutated genes passed from parent to children. Growing awareness of breast cancer increases the adoption of genetic testing for hereditary breast cancer.
Further, as per CDC, sickle cell disease (SCD) is a common genetic blood disorder in the US that affects ~70,000 to 100,000 Americans. Further, as per the WHO, 5% of the world population is the carrier of the genes for hemoglobin disorders, such as sickle-cell disease and thalassemia. Thus, the increasing prevalence of such genetic diseases propels the demand for molecular quality controls.
Based on product, the molecular quality controls market is segmented into independent controls and instrument specific controls. The independent controls segment held a larger share of the market in 2020, whereas the same is anticipated to register the highest CAGR in the market during the forecast period.
Get more information on this report :
Based on analyte type, the molecular quality controls market is segmented into single analyte controls and multi-analyte controls. The single analyte controls segment held a larger share of the market in 2021, whereas the multi-analyte control segment is estimated to register the highest CAGR in the market during the forecast period.
Based on application, the molecular quality control market is segmented into infectious diseases, oncology, genetic testing, and other applications. The infectious diseases segment held the largest share of the market in 2021, whereas the oncology segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on end user, the molecular quality control market is segmented into clinical laboratories, hospitals, IVD manufacturers & contract research organizations, academic & research institutes, and other end users. The Clinical Laboratories segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of in the market during the forecast period.
|Market Size Value in||US$ 184.62 Million in 2021|
|Market Size Value by||US$ 372.64 Million by 2028|
|Growth rate||CAGR of 10.6% from 2021-2028|
|No. of Pages||204|
|No. of Tables||138|
|No. of Charts & Figures||77|
|Historical data available||Yes|
|Segments covered||Product , Analyte Type , Application , and End User and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the molecular quality controls market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.
The List of Companies - Molecular Quality Controls Market